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Inorganic arsenic (In-As) is known to
increase the risk of cancer at several target
sites. Inhalation of arsenic, mainly from
dust exposure in occupational settings such
as metal smelters and pesticide production,
increases the risk of lung cancer while
ingestion of arsenic, mainly from contami-
nated drinking water sources, causes skin
cancer (1). Epidemiological evidence also
indicates that In-As ingestion is associated
with increased risks of lung, bladder, kid-
ney, and liver cancers (2-5). Based on data
from studies conducted in Taiwan, we esti-
mated that at the present EPA arsenic water
standard of 50 jig/l, the risk of internal can-
cers could be of comparable magnitude to
those from environmental tobacco smoke
and radon in homes (6). Similar cancer
risks from arsenic in drinking water were
derived by Chen et al. (7) in another risk
assessment based on the same data.
In-As can be ingested as either arsenite
(AsIII) or arsenate (AsV). Although AsV is
less toxic, it is reduced biologically to
AsIII prior to undergoing methylation,
which is considered a detoxification mech-
anism for In-As (8,9). Two methylation
steps take place, the first producing
monomethylarsonate (MMA), which is
then further methylated to dimethylarsi-
nate (DMA). Both MMA and DMA are
considered less toxic and bind less to tis-
sues than In-As (8).
It has been proposed that saturation of
the methylation capacity may lead to a
threshold for the carcinogenicity of ingest-
ed In-As (8,10). Under this hypothesis, as
exposure increases, one would expect to see
an increase in the proportion of In-As (the
more toxic species), with a corresponding
decrease in MMA and DMA.
Urinary arsenic is generally regarded as
the most reliable indicator of recent expo-
sure to In-As and is used as the main bio-
marker of exposure (11,12). In the case of
ingestion, experimental studies show that
around 60-75% of the dose is excreted in
the urine within a few days (8,9,13).
Blood arsenic is not considered a good
indicator because it is cleared within a few
hours (11,14). Although In-As accumu-
lates in hair and nails, external surface
arsenic contamination make these samples
less accurate for assessing dose (15).
While total urinary arsenic has been used
to assess In-As exposure, it is important to
differentiate In-As and its metabolites from
other organic forms. In particular, certain
types of seafood contain arsenobetaine, a
much less toxic organic form of arsenic that
is excreted quickly in the urine. Using meth-
ods of speciation analysis, In-As, MMA, and
DMA can be separated from other arsenic
compounds. Currrently, the sum of these
species in urine constitute the preferred mea-
sure of exposure to In-As and, for conve-
nience, we will refer to it as total arsenic (Tot-
As). The relative proportions of urinary In-
As, MMA, and DMA have been used as indi-
cators of methylation capacity (6,16-19).
In a previous report, we examined the
results of several studies reporting speciated
urinary arsenic measures. Collectively, they
showed that the published evidence ofhuman
studies did not support the methylation
threshold hypothesis (17). The relative per-
centages of In-As, MMA, and DMA averaged
approximately 15-20%, 10-15%, and
60-70%, respectively, across different popu-
lations studied, with no systematic increase in
the percent In-As with increasing exposure.
More recently, we conducted two studies of
populations exposed to unusually high arsenic
levels in drinking water. One study in Nevada
compared individuals drinking well water
containing arsenic levels over 500 pg/l (mean
= 1300 pig/l) to an unexposed group drinking
water with an average of 16 pg/l (18). In a
larger investigation conducted in Chile, we
compared methylation patterns of 122 people
from a town with around 600 I/l arsenic in
water to 108 people from a neighboring town
with 15 pg/l (20). Both studies found that
methylation patterns did not vary greatly by
exposure levels while, in contrast, they noted
large interindividual variability independent
of exposure level. In addition, other factors
such as gender, smoking, and ethnicity
seemed to have a greater effect on species dis-
tributions than did urinary arsenic levels. The
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influence of these other factors applied main-
ly to the relative proportions of MMA and
DMA (summarized as the MMA/DMA
ratio), but not to the percent In-As.
All of the studies conducted so far have
been cross-sectional in nature, either com-
paring individuals of similar arsenic expo-
sure levels (background, occupational, or
environmental) or of contrasting exposures
(high versus low exposure groups). There
have been no previous population studies
reporting the effects of changing exposure
on methylation patterns. In this study, a
subgroup of highly exposed subjects from
the previously reported study in northern
Chile (20) were provided with water con-
taining lower arsenic levels (45 pg/l) for a 2-
month period. Urinary arsenic was collected
before and at the end of the intervention
phase. We investigated the effects of change
in arsenic exposure on the patterns of uri-
nary metabolites as a measure of methyla-
tion capacity in a longitudinal follow-up
using each person as his/her own control.
Methods
Study population. Study subjects were resi-
dents of San Pedro de Atacama, a town of
1600 people in the Atacama Desert of
northern Chile, previously found to have
high arsenic levels in their water supply
(21,22). The water sources derive from
surface waters originating in the Andes
mountains, and their arsenic content
depends on the natural geological composi-
tion of their course (22). San Pedro has
two sources of drinking water: water from
the Vilama river, which is piped to most
homes and contains around 600 pg As/l,
and water from the San Pedro river, with
about 170 pg As/l, which is used by some
homes having no public water supply.
Participants for this study were a subset
of those of a larger investigation, described
in detail elsewhere (20,23,24). Briefly,
prospective study subjects were recruited
through public announcements, meetings,
and door-to-door contact. They had to be
at least 18 years old and to have lived in the
town for the last 3 months. A cross-sec-
tional study was conducted, comparing res-
idents of San Pedro to those of a neighbor-
ing town having low arsenic water. All
study subjects were interviewed by trained
interviewers regarding general characteris-
tics; smoking and drinking habits; and
medical, occupational, and residential his-
tories; first morning urine samples were
obtained as described below.
For the intervention study reported
here, we selected a subsample of partici-
pants from San Pedro, including only resi-
dents who drank from the higher arsenic
water source (tap water). For a 2-month
period, they were provided with water con-
taining a lower arsenic concentration. The
only available source of water for this pur-
pose was from the town of Calama, located
about 100 km from San Pedro, which has a
water supply with about 45 pg As/I. Water
was brought in twice a week by truck and
delivered to participants' homes in 60-liter
containers, which were equipped with spig-
ots. Participants agreed to use this water for
all drinking and cooking purposes.
About 40 homes were enrolled in the
intervention study, from which 78 persons
participated (not counting other family
members, primarily children, who lived in
the same house and used the water but were
not study subjects). During the 2 months of
the study, there were two urine sample col-
lection periods about 2-3 weeks apart to
monitor compliance by study participants
in using the provided water. At the end of
the study period, all subjects were inter-
viewed and sampled again while they were
still receiving the lower arsenic water.
Laboratory analysis. First morning
urine samples were obtained and kept
frozen in the field laboratory at -20°C until
they were transported in dry ice to the
University of Washington in Seattle. They
were analyzed for arsenic content by
hydride generation atomic absorption spec-
troscopy (HGAA) based on Andreae's
method (25) as described for our cross-sec-
tional study (20). Briefly, In-As, MMA,
and DMA were reduced to their corre-
sponding arsines with sodium borohydride
and were subsequently measured by atomic
absorption spectroscopy. Detection limits
for In-As, MMA, and DMA were 0.5 pg/l,
1.0 pig/l, and 2 pg/l, respectively.
Some samples were found to have an
unusually low proportion of methylated
species. Replicates of these samples were
tested by spiking in the laboratory with a
mixture of known amounts of In-As,
MMA, and DMA, which revealed striking-
ly low recoveries (less than 25%) ofMMA
and especially DMA. It was concluded
that, for those samples, the methylation
assay suffered from interference from an
unidentified substance. An alternate
method was derived, which resulted in
more complete recovery of the methylated
species but yielded a slightly lower recovery
for In-As. Due to differences in methodol-
ogy and in recovery rates and given that it
affected only a few samples from the inter-
vention subgroup (n = 4), they were omit-
ted from this analysis.
During the study, water samples were
taken from the water supply and analyzed
for arsenic content by HGAA according to
a procedure similar to that used for urine
specimens (26). Urine samples were also
assayed for creatinine content to allow
expression of Tot-As in relation to urine
concentration.
Statistical analysis. Sociodemographic
and lifestyle characteristics of study partici-
pants were compared to describe their distri-
bution by age, gender, ethnicity, education,
length of residence, smoking habits, and
drinking of alcoholic beverages. Compliance
with usage of the provided water was assessed
by comparing the different Tot-As measure-
ments of urine samples taken before, during,
and at the end of the intervention phase.
Tot-As (In-As + MMA + DMA) was
used as the measure of exposure. Our previ-
ous analysis of the creatinine-adjusted
(micrograms As per gram of creatinine) and
unadjusted values (micrograms As per liter
of urine) led us to use the latter (20). In
brief, creatinine excretion can vary consider-
ably by a number of exogenous and endoge-
nous factors (27). The results of our cross-
sectional methylation study in this same
population showed that the distribution of
In-As metabolites did not vary by urinary
creatinine concentrations nor were there any
major differences in using creatinine-adjust-
ed or unadjusted Tot-As values (20). In this
study, the same comparisons were per-
formed and showed no substantial differ-
ences; therefore, we decided to use unadjust-
ed urinary arsenic concentrations in the cur-
rent analysis as well.
Table 1. General characteristics of study subjects
Characteristic Mean (percent) Range
Gender
Male (n= 39) (53)
Female (n= 34) (47)
Age
Male 42.6 20-74
Female 43.1 18-81
Years of residence 21.0 <1-81
<5 years (8)
.5 years to <15 yrs (32)
.15 years (60)
Years of education 6.1 0-16
Ethnicity
Atacamenos (79)
Aymara/Mapuche (4)
European (4)
Other (10)
Unknown (3)
Smokers
Male (n= 12) (31)
Female (n= 10) (29)
Smokers of .1/day
Male (n = 7) 6.0a
Female (n = 7) 5.6a
Drink any alcohol
Male (n= 26) (67)
Female (n= 13) (38)
Drinkers of .1 drink/week
Male (n= 23) 9.4b
Female (n= 8) 2.2b
aMean per day.
bMean per week.
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For the analyses of the distribution of
arsenic metabolites, Tot-As, the percentages
of In-As, MMA, and DMA, and the
MMA/DMA ratio were calculated for each
of the two sampling periods: before the
change in water supply and after the 2
months oflower arsenic water usage (referred
to as before or initial and after or final mea-
surements). The mean of each period was
derived by first calculating each individual
measurement and then averaging over the
group. Since attention has recendy focused
on the MMA/DMA ratio (19,28), we also
conducted analyses using this measure.
The distribution of arsenic species
before and after intervention were com-
pared for the group as a whole and then
stratified by gender, age, years of residence,
ethnicity, and smoking and alcohol drink-
ing habits. These factors had been associat-
ed with methylation in the cross-sectional
comparison of the low and high exposure
towns (20). In order to quantify the magni-
tude of the change in percent In-As, percent
MMA, percent DMA, and MMA/DMA
between the two sampling periods, a mea-
sure of change was derived, calculated by
subtracting the second measure from the
first (before - after). The associations
between the magnitude of this difference or
measure of change in the distribution of
metabolites and that of the change in Tot-
As (before - after) were evaluated.
Table 2. Mean urinary arsenic metabolite distribution by various factors
Characteristic Total As (pg/I) Percent In-As Percent MMA Percent DMA MM/M
All (n =73) Before8 636 (133-1893) 17.8 (7.3-38.8) 14.8 (3.7-26.8) 51.4(44.7-85.1) 0.300-.0
p-value' <0.001 <0.001 <0.001 <0.001
Gender
- "'jI* I *flflInfl U atettn~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~[i0ur~~~~~~~~~~~urrr~~~~~~~~~~~~~~~~~w,~~~~~~~~~~~~~~ g!ViI ii I IVuE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ID F~~ ~ U1
After 189(38-429) 15.5(3.3-27.8)i 3 (4.6-26.5) 70.7 (49.4-90.4)b.20(0.06-0.40)~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~n.1ss
Age~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~W
After 2089(44.-4219) 16.0(6.3-25.8) 14.6(4.9-22.1) 69.5(57.3-890) 0.22 (0.06-046
v.I....>30to<50years (n= 32)~~~~~~~~~~~~~~.......... Beor74(27183 17(538 i37 3.-2.6 .(4.7824 ~_O _02 00-.7
YL:L~~~U~t~~L:~Y ~~:4I{t"t ~~~~ ~h JItZIF~1 -.hi9g2
Nomle(n51) Before 65(21396-1893) 17.3(7.3-38.8) 13.8 (3.7-2.5) 58.9(44.7-85.1) 02 00-.1
p-value <0.001 0.002 <0.001 <0.001 <0.051
Age"Rfv ~)~L ~ ~ I E!p 3 i U h .nAfter~~~~~~~~~~~~~~~~~~n17(12)1.(.-83 3248213 105.-89 .000-.2
After 1708(2294219) 15.9(3.3-2583) 14.3 (4.6-27.1) 69.8 (49.3-90A) 02(0.060.5
*.*..**.**. ,,~~~~~~~~~~~~~~~~~..... .9 'F, MI
Atacam0eno s(n=8 Before 6460(196-1893) 17.9(7.45-38.8) 13.4(3.7-26.6) 67.7 (44.7-824.) 0.200-.6
p-value <0.0010 0.00 0.028.4
After 1532(22-356) 16.1 (9.7-28.3) i3.9 (4.4-21.8) 70.90(40.3-90.1) 0.21 (0.05-0.42)
>15 years(n 44) Before 580(196-1552) 17.0(7.3-38.8)~~q s p1407.-8.)690(4.-6.) 0.22(I0.09-.56
p-value <0.001~~~~~~~~~~~~~~~~In As inorganic arsenic;MMA, monomethylarsonate; DMA, dimethylarsinate
'Paire ttestH I giMN mWaives are give as mean(rage)
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Multiple regression analysis was used to
examine the effect of various factors on the
distribution of metabolites before and after
intervention, including Tot-As, gender, age,
smoking, and years of residence. The same
type of analysis was performed using the
measures of change in metabolite distribu-
tion between the two periods as the outcome
variables to assess the potential contribution
of other factors to the differences observed.
Results
The study group originally consisted of 78
participants, but 4 were excluded from the
final analysis for irregularities in the urinary
speciation assay as explained above. One
additional subject was excluded because of
evidence that he was dearly not complying
with the intervention plan: three urine sam-
ples taken during that time were consistent-
ly very high and of the same general level as
the initial preintervention sampling (first =
939 pg/l; subsequent three were 1162, 737,
and 1344). Therefore, the final study sam-
ple included 73 participants.
The distribution ofgeneral characteristics
is summarized in Table 1. A similar number
ofmen (n = 39) and women (n = 34) partici-
pated, and most ofthem were long-time resi-
dents (92% had lived in San Pedro for at
least 5 years) and were ofAtacamefio ethnici-
ty (79%). About the same percentage ofmen
and women were smokers, while almost
twice as many men than women reported
drinking alcohol (67% vs. 38%). Because we
found it common for people to report smok-
ing or drinking occasionally, we also com-
pared smokers who smoked at least one ciga-
rette per day (regular smokers) to nonsmok-
ers and drinkers who consumed at least one
drink per week (regular drinkers) to non-
drinkers [one drink was defined as 355 ml
Table 3. Total arsenic (Tot-As), percent inorganic
arsenic (percent In-As), and monomethylarsonate/
dimethylarsinate ratio (MMANDMA) for study sub-
jects having four total urine samples (n = 44)
Measurement Mean ± SD Range
Tot-As
Beforea 696 ± 402 212-1893
2b 213 ± 192 39-1162
3b 198 ± 173 30-737
4c 185 ± 215 22-1344
Percent In-As
Before 17.8 ± 7.6 7-39
2 13.0±5.5 6-36
3 14.6±7.1 6-35
4 13.9±5.7 3-31
MMANDMA
Before 0.23 ± 0.11 0.05-0.56
2 0.16 ± 0.06 0.07-0.32
3 0.17 ± 0.07 0.03-0.38
4 0.17±0.11 0.05-0.55
aPrior to change in water supply.
bDuring intervention period.
cEnd of the study period.
beer, 118 ml wine, 30 ml liquor, 355 ml
aloja (an alcoholic beverage made from fer-
mented pods of the Algarrobo tree)]. The
average number of cigarettes per day among
regular smokers was around 6 for both men
and women, while among regular drinkers
men drank more than three times as much as
women (9.4 vs. 2.2 average drinks per week).
The results of arsenic water analyses
conducted during the study period for San
Pedro tap water ranged from 615 to 670
pg/l, which is consistent with levels report-
ed in previous investigations (21,22). The
arsenic concentration of the water delivered
to participants during the intervention peri-
od was 45 jig/l. All the As was in the inor-
ganic form, but the assay we used for water
measurements did not distinguish the oxi-
dation state of In-As. However, a previous
study in the same area, which used a differ-
ent method, found that the As was practi-
cally all in the pentavalent form (AsV) (21).
Stratified comparisons of arsenic metabo-
lite species before and after intervention are
presented in Table 2. Although all four mea-
sures (percent In-As, percent MMA, percent
DMA, and MMA/DMA) are shown, for the
sake of brevity we will mainly limit our dis-
cussion below to percent In-As and the
MMA/DMA ratio. The average urinary lev-
els of Tot-As before and after intervention
were 636 pg/l and 166 pig/l, respectively.
The effect of intervention on species distrib-
ution for all participants combined showed a
mean decrease of 3.2 (from 17.8 to 14.6) in
the percent In-As and a decrease of 0.05
(from 0.23 to 0.18) in the MMA/DMA
ratio. There were 28 people whose Tot-As
decreased to levels below 100 pg/l (from 457
WI to 65 pg/l) and 9 who had final concen-
trations under 50 pg/l (from 431 l to 38
pg/1). For these two groups, the final average
percent In-As and MMA/DMA ratios were
14.2% and 14.7% and 0.17 and 0.14,
respectively. A large variability between indi-
viduals was observed (overall group range in
percent In-As change was -11.1 - +23.9 and
in the MMA/DMA ratio was -0.31 - +0.27).
During the intervention phase, an
attempt was made to collect urine on two
different occasions, but not all subjects par-
ticipated, mainly because they were not avail-
able at the time they were visited. As a result,
two follow-up urine samples were collected
from 44 study participants. For this subset of
subjects, the average Tot-As before interven-
tion was 696 /1, and the subsequent three
measures, starting about 2-3 weeks after the
change in water supply and ending at the
final sample collection period 2 months later,
were quite similar: 213 jig/l, 198 pg/l, and
185 WI. The same type of pattern was seen
for the percent In-As and the MMA/DMA
ratio across the four samples obtained for this
study subgroup (Table 3).
The overall changes in percent In-As and
the MMA/DMA ratio are plotted against the
corresponding changes in Tot-As in Figure
1. The line going through zero on the y-axis
denotes no change, while a negative value for
the change means a decrease in percentage or
ratio (value after intervention lower than
before). The values on the x-axis correspond
to the change in Tot-As from before to after
intervention. These graphs indicate two
main findings: most participants experienced
some decrease in percent In-As and in
MMA/DMA (67% and 78% of the group,
respectively) and the magnitude of the
decrease did not appear to be associated with
the magnitude of the decrease in Tot-As.
Stratification on gender showed that
initially men had a higher average percent
In-As and a higher MMA/DMA ratio than
women (18.8% vs. 16.8% and 0.27 vs.
0.19, respectively) and that, after interven-
tion, they experienced the same mean
decrease of 3.2 in percent In-As. However,
men had over twice the decrease in
MMA/DMA ratio than women (0.27-0.20
vs. 0.19-0.16). Stratification by age did
not show a clear pattern, although the old-
est group (>50 years old) seemed to have
the greatest changes. Participants with less
than 5 years duration of residence in the
town showed a greater change both in per-
cent In-As and in MMA/DMA ratio than
longer duration residents (Table 2). The
correlation between age and length of resi-
dence was not very high (r = 0.35) so that
the two variables are likely to contribute
independent effects.
In the comparison by ethnicity, because
80% were ofAtacamefio origin, we divided
the group into Atacamefios and all others
combined (which included other indige-
nous groups as well as people of European
and unknown origin). Both groups had
about the same initial mean percent In-As,
and similar decreases after the 2 months,
but because Atacamefios had a lower
MMA/DMA ratio initially (0.22 vs. 0.27),
a similar ratio following intervention
resulted in a greater change for the non-
Atacamefio group. However, the small,
heterogeneous nature of this group (three
European, three Aymara/Mapuche, seven
other, two unknown) made the comparison
hard to interpret. When ethnicity was
entered into the multiple regression analy-
sis, dichotomized as Atacamefio and non-
Atacamefno, the coefficient was not statisti-
cally significant (not shown). For these rea-
sons, we chose not to include ethnicity in
the final regression models.
When categorized by smoking status,
nonsmokers had a somewhat lower initial
proportion of In-As than smokers (17.3%
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versus 19.0%), and both had the same
mean decrease of 3.2 (Table 2). With
respect to the changes in MMA/DMA
ratio, smokers had higher initial values and
experienced three times the decrease than
nonsmokers (0.29-0.20 vs. 0.21-0.18).
The differences were slightly greater when
regular smokers (subgoup of smokers) were
compared to nonsmokers (data not shown).
Since stratification by smoking status
showed the largest differences, the changes in
percent In-As and MMAIDMA relative to
Tot-As change were examined separately for
smokers and nonsmokers. Both groups had
quite similar changes in percent In-As, with
64% and 67% showing a decrease, respec-
tively. However, the difference between
smokers and nonsmokers in MMA/DMA
ratio was quite clear, since all but one of the
smokers (21/22 or 95%) had a decrease in
the ratio (Fig. 2A), while among nonsmok-
ers, 70% (36/51) had a decrease (Fig. 2B).
In general, the results show that greater
changes occurred in the MMA/DMA ratio
than in percent In-As, and the subgroups
with the highest mean MMA/DMA values
before the intervention showed a sharper
decrease in the MMA/DMA ratio at the end
of the study. In particular, smokers and men
showed the greatest changes with respect to
nonsmokers and women, respectively.
The results of the regression analysis
using percent In-As and MMA/DMA as the
dependent variables are presented in Table
4, showing three regression models for each
outcome: one for before (A and D), one for
after intervention (B and E), and one using
the change in percent In-As or MMAIDMA
over the intervention period (C and F). The
distribution of arsenic species both before
and after intervention did not reveal any
clear association between Tot-As levels and
the percent In-As (models A, B) or the
MMA/DMA ratio (models D, E). In con-
trast, a wide range of interindividual varia-
tion was observed, with a range of 0.05-0.6
for the MMA/DMA ratio across all study
subjects, for each of the two sampling peri-
ods (Table 2). Similarly, there was no associ-
ation between the change in urinary Tot-As
(from before to after intervention) and the
change in percent In-As or MMA/DMA.
Smoking and being male were associated
with somewhat smaller MMA/DMA ratios
before and after intervention, while no asso-
ciations were found with percent In-As. Age
did not show any significant effect. Length of
residence was associated with percent In-As
and MMA/DMA before but not after inter-
vention, but the small coefficients indicate a
minor effect (a 1% decrease in percent In-As
and less than 0.02 decrease in MMA/DMA
for 10 years of residence in San Pedro). The
only variable associated with the change in
MMA/DMA (from before to after the water
change) was length of duration in the town.
In general, the magnitude of all coefficients
indicate the variables analyzed did not con-
tribute substantially to the observed varia-
tions in percent In-As and MMA/DMA.
Discussion
This is the first epidemiological study to
investigate the effect of reducing exposure
on arsenic methylation patterns in a popu-
lation with chronic environmental exposure
to In-As from drinking water. In addition,
this research design has the advantage of
having each person serve as his/her own
control, thus reducing interindividual vari-
ability found when comparing two popula-
tions with contrasting exposures.
Following 2 months of receiving an
alternate water supply with lower arsenic
concentration, a substantial decrease in the
mean urinary Tot-As was observed.
However, the final urinary levels were
higher than what would be expected from
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Figure 2. Change in monomethylarsonate/di
arsenic (Tot-As) for smokers (A) and nonsrm
water.
-50 pg higher levels could also be partly attributed arsenic exposure on urinary excretion has
In-As to arsenic stores in internal tissues from not been monitored constantly over time
a rea- previous exposure. Studies of volunteers among chronically exposed persons, which
:ipants show that 50-70% of a single ingested could have a different pharmacokinetic
utside dose of In-As is excreted within a few days profile from potentially higher stores in
grown (13,14,29,30). In one investigation, four internal tissues. In our study, the follow-up
rming subjects were given different arsenic doses samples taken during the intervention peri-
aining for 5 days. Following 14 days of urinary od at about 2-3 week intervals on 44 par-
e was monitoring (9 days after exposure ticipants did not show any substantial pat-
bjects stopped), levels went down to near back- tern of decrease in Tot-As after the first fol-
iter at ground concentrations (31). However, the low-up sample, indicating that, after a cou-
v. The effect of reduction from high to lower ple of weeks, a new steady state had likely
been reached. It is also noteworthy that the
mean percent In-As and MMA/DMA
remained quite constant after the initial
small reduction following the change in
water supply.
In this study, the overall distribution of
In-As metabolites was similar before and
after intervention, with wide interindividual
variations observed for both sampling peri-
ods. The 2 months of intervention were
accompanied by a general small decrease in
the percent In-As and percent MMA, a cor-
respondingly small increase in percent
DMA, and a decrease in the MMA/DMA
ratio. The differences observed between
before and after the water supply change
were within the ranges of those seen
between San Pedro and the lower exposure
town in our cross-sectional study in the
same population (20), even though the con-
trast in mean Tot-As were somewhat higher
-1000 0400 -600 ° 0 0 200 between the two exposure towns (583 pg/l
vs. 61 pg/l) than between the before/after
Change in Tot-As (ig/l) intervention (636 pg/l vs. 166 pg/l).
Although there was a general decrease
tpq~ in percent In-As and in the MMA/DMA
ratio, suggesting a slight improvement in
methylation capacity, the magnitudes of
the changes in metabolite distributions
were small and were not related to the
magnitude of the decrease in urinary Tot-
As (Fig. 1). The change was greater for the
MMA/DMA ratio than for the percent In-
As, which is again in agreement with our
cross-sectional study findings, comparing
methylation patterns between the two
exposure towns.
Our findings of an increase in MMA
relative to DMA are supported by experi-
mental studies in vitro with rat liver
cytosol, which suggest that high In-As con-
centrations inhibit only the second methy-
lation step (32). However, the large vari-
ability observed and the relatively small
magnitude of the change in relation to
interindividual variations in this human
-1000 -800 -600 -400 -200 0 200 population implies that the role of In-As
exposure is minor in determining methyla-
tion, as measured by the distribution of
imethylarsinate (MMA/DMA) relative to change in total urinary urinary metabolites. In fact, even before
okers (B) after reduction of arsenic concentrations in drinking intervention, this group with average Tot-
As urinary levels over 600 pg/l showed
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Table 4. Multiple linear regression results using percent inorganic arsenic (percent In-As) and
monomethylarsonate/dimethylarsinate ratio (MMANDMA) as the dependent variables (n = 72)a
Models Coefficient SE p-value
A) Percent In-As before intervention (R2 = 0.10)
Total arsenic (pg/I) -0.00076 0.0022 0.73
Gender (male vs. female) 1.67 1.55 0.29
Age (years) -0.0067 0.056 0.91
Length of residence (years) -0.11 0.055 0.05
Smoking (cigarettes/day) 0.12 0.21 0.58
B) Percent In-As after intervention (R2 = 0.08)
Total arsenic (pg/I) 0.00016 0.0056 0.98
Gender (male vs. female) 1.82 1.28 0.16
Age (years) -0.046 0.045 0.31
Length of residence (years) -0.029 0.045 0.52
Smoking (cigarettes/day) 0.14 0.17 0.42
C) Percent In-As difference (before - after intervention) (R2 = 0.04)
Total arsenic difference (pg/I) 0.0022 0.0023 0.34
Gender (male vs. female) -0.42 1.66 0.80
Age (years) 0.051 0.060 0.39
Length of residence (years) -0.079 0.60 0.19
Smoking (cigarettes/day) -0.023 0.23 0.92
D) MMA/DMA before intervention (R2 = 0.32)
Total arsenic (pg/I) 0.000018 0.000032 0.58
Gender (male vs. female) 0.068 0.023 0.004
Age (years) 0.000093 0.00081 0.91
Length of residence (years) -0.0018 0.00081 0.033
Smoking (cigarettes/day) 0.0091 0.0031 0.005
E) MMA/DMA after intervention (R2 = 0.16)
Total arsenic (pg/I) 0.000058 0.00011 0.58
Gender (male vs. female) 0.048 0.024 0.052
Age (years) -0.0015 0.00085 0.082
Length of residence (years) -0.000063 0.00085 0.46
Smoking (cigarettes/day) 0.00064 0.0033 0.057
F) MMANDMA difference (before - after intervention) (R2 = 0.15)
Total arsenic difference (pg/I) 0.000013 0.000033 0.70
Gender (male vs. female) 0.019 0.024 0.44
Age (years) 0.0016 0.00087 0.066
Length of residence (years) -0.0024 0.00087 0.007
Smoking (cigarettes/day) 0.0025 0.0034 0.45
aFor the total study group n = 73; in the regression analyses, n = 72 because of one missing value for one
of the variables included (cigarettes/day).
metabolite distributions well within the
ranges described for other populations with
much lower exposures (17,33,34).
The greatest changes in the MMA/
DMA ratio occurred among the subgroups
that appeared to be less efficient methylators
at the second methylation step (e.g., smok-
ers and men), and the differences were simi-
lar to those reported for the cross-sectional
study (20). However, the greater change in
those subgroups resulted not from general
decreases of greater magnitude (as shown in
Fig. 2) but rather to a more consistent pat-
tern of changing in the same direction.
Particularly for smokers, practically all
showed a decrease in their MMA/DMA
ratio. As suggested previously (20), it is pos-
sible that chemicals in cigarette smoke com-
pete for some of the same detoxification
enzymes or co-factors as for In-As methyla-
tion, particularly in the second methylation
step. Experimental studies have shown that
the addition of mercuric ions to a culture
media treated with In-As has an inhibitory
effect on the production ofDMA relative to
MMA, but not on the first methylation
reaction (35). This finding is consistent
with the fact that detoxification of both In-
As and Hg are thiol dependent (36).
Because S-methyltransferases have a thiol
(sulphydryl) group as the substrate, under
high exposures or competitive substrates, the
activity of the second methyltransferase
appears to be the rate-limiting step.
Smoking involves the intake of such a myri-
ad of chemicals that such a scenario is plau-
sible with other thiol-dependent toxicants.
Given the incomplete knowledge of the
steps involved in arsenic detoxification, the
nature or magnitude of substrate competi-
tion cannot be currently ascertained.
Genetic polymorphisms in the activity
of enzymes or related co-factors in one or
more of the steps of arsenic detoxification
are likely to play an important role in what
still remains as unexplained variations
between individuals. Support for this comes
from several sources, including the large
genetic variability found for the activity of
methyltransferases involved in drug metab-
olism and clinical pharmacology (37,38).
Similarly, glutathione is known to play a
role in several steps of In-As detoxification,
and genotypical differences have been
described for glutathione transferases, for
example, in relation to ethnicity, with over
twofold variations between groups (39).
The effects of factors such as gender
and age on arsenic methylation capacity
remain to be explained, although they do
not seem to explain variability to a great
extent. The level of arsenic exposure does
not appear to have a significant impact on
the percent In-As, but its effect is some-
what greater in relation to the MMA/DMA
ratio. This finding was very similar in the
comparison of high and low exposure
towns in the same study area (20) and in
the comparison of before and after inter-
vention presented in this study.
In conclusion, several factors have
impacted differerently on the effect of
decreasing arsenic exposure on the distribu-
tion of In-As metabolites. Most of the dif-
ferences were found for the MMA/DMA
ratio, but the significance of these findings
to human health remains unclear. In addi-
tion, most of the variability was not
explained by exposure levels or by the other
variables investigated, and the role of
genetic variability in factors related to the
metabolism of In-As, as well as the effect of
other concurrent exposures or lifestyle fac-
tors, need to be investigated. However, the
data produced to date in population studies
is quite definitive in concluding that sub-
stantial proportions of In-As, MMA, and
DMA are found across wide ranges of
exposure levels and that there is no evi-
dence of an exposure-based threshold for
arsenic methylation in humans.
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